Orca-T Approved to Prevent GVHD After Stem Cell Transplant for Blood Cancers

[ad_1]

(MedPage Today) — The FDA approved an allogeneic regulatory T cell-based immunotherapy product with hematopoietic stem and progenitor cells (HSPCs) and T cells (Tregzi) to prevent serious complications of stem cell transplants for hematologic…

[ad_2]

Source link : https://www.medpagetoday.com/hematologyoncology/leukemia/122012

Author :

Publish date : 2026-07-01 18:00:00

Copyright for syndicated content belongs to the linked Source.